Protagonist Therapeutics Inc (PTGX)
28.31
+1.20
(+4.43%)
USD |
NASDAQ |
May 09, 16:00
28.28
-0.04
(-0.12%)
After-Hours: 20:00
Protagonist Therapeutics Profit Margin (Quarterly): 81.32% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 81.32% |
December 31, 2023 | 45.56% |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | -4.78K% |
March 31, 2022 | -81.37% |
December 31, 2021 | -428.3% |
September 30, 2021 | -328.6% |
June 30, 2021 | -1.36K% |
March 31, 2021 | -387.8% |
December 31, 2020 | -334.3% |
Date | Value |
---|---|
September 30, 2020 | -59.20% |
June 30, 2020 | -312.4% |
March 31, 2020 | -550.6% |
December 31, 2019 | -643.7% |
September 30, 2019 | -396.3% |
June 30, 2019 | |
March 31, 2019 | -904.0% |
December 31, 2018 | -589.2% |
September 30, 2018 | -142.8% |
June 30, 2018 | -74.21% |
March 31, 2018 | -71.06% |
December 31, 2017 | -27.05% |
September 30, 2017 | -54.95% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-4.78K%
Minimum
Jun 2022
81.32%
Maximum
Mar 2024
-681.0%
Average
-361.0%
Median
Profit Margin (Quarterly) Benchmarks
Lifecore Biomedical Inc | -- |
SELLAS Life Sciences Group Inc | -- |
Akebia Therapeutics Inc | 1.09% |
Immuneering Corp | -- |
Moderna Inc | -703.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 47.41% |
Return on Assets | 43.17% |
Return on Invested Capital | 47.41% |
Operating Margin (Quarterly) | 80.92% |
Return on Net Operating Assets | 234.7% |